Literature DB >> 7925565

Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells.

R Scully1, S Qin, S Cobbold, H Waldmann.   

Abstract

CBA/Ca mice may be made tolerant to minor histoincompatible B10.BR skin grafts by treatment with a short course of non-depleting anti-mouse CD4 and CD8 monoclonal antibodies (mAb), during the transplantation period. We wished to determine when, in relation to antibody therapy, the T cells became tolerant. This was investigated by a series of adoptive transfer experiments in which mAb-treated cells were removed from therapeutic antibody at defined times after skin grafting, and exposed to fresh antigen in the absence of further mAb treatment. We show here that T cells do not become fully tolerant until 5 weeks after skin grafting. If antibody therapy is continued for the full 5 weeks, T cell tolerance can still be established, suggesting that antibody therapy does not prevent lymphocytes from registering the presence of antigen. Once the tolerant state is established, it is difficult to break that tolerance by lymphocyte infusions from normal donors. This "resistance" is mediated by T cells of the tolerant host. We show that the maintenance of both tolerance and "resistance" requires a continuous supply of antigen. When tolerant cells were "parked" in T cell-depleted mice, tolerance and "resistance" were eventually lost by 6 months. In contrast, "parked" cells exposed to fresh antigen at any time up to 4 months remained tolerant and "resistant" indefinitely. Finally, we wished to establish whether "resistance" was peculiar to this form of peripheral tolerance, or whether it might also be present in tolerance considered to be classically central. We observed resistance to be greater in the mAb-treated peripherally tolerant group, but noted that some of the centrally tolerant animals also exhibited a level of resistance above that of T cell-ablated controls. This suggests that a tolerance mechanism whose role is only minor in central tolerance may have a major role in antibody-mediated peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925565     DOI: 10.1002/eji.1830241019

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.

Authors:  Luis Graca; Stephen Daley; Paul J Fairchild; Stephen P Cobbold; Herman Waldmann
Journal:  BMC Immunol       Date:  2006-04-25       Impact factor: 3.615

Review 2.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 3.  Regulatory T cells in pregnancy.

Authors:  Ana Claudia Zenclussen
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

4.  Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.

Authors:  Ling Weng; Julian Dyson; Francesco Dazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

5.  Regulation and privilege in transplantation tolerance.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  J Clin Immunol       Date:  2008-09-06       Impact factor: 8.317

6.  Long-term control of alloreactive B cell responses by the suppression of T cell help.

Authors:  Yijin Li; Lianli Ma; Dengping Yin; JiKun Shen; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 7.  Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

Authors:  Herman Waldmann; Robert Hilbrands; Duncan Howie; Stephen Cobbold
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 8.  The battle against immunopathology: infectious tolerance mediated by regulatory T cells.

Authors:  David M Gravano; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2011-12-29       Impact factor: 9.261

Review 9.  T cell tolerance induced by therapeutic antibodies.

Authors:  Stephen P Cobbold
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 10.  Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulation.

Authors:  Mariela Glandt; Kevan C Herold
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.